Literature DB >> 12926730

Introduction of the National Meningococcal C Vaccination Program.

Natalie J Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12926730

Source DB:  PubMed          Journal:  Commun Dis Intell Q Rep        ISSN： 1447-4514


× No keyword cloud information.
  4 in total

Review 1.  The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine.

Authors:  Robert Welte; Caroline L Trotter; W John Edmunds; Maarten J Postma; Philippe Beutels
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  Using linked birth, notification, hospital and mortality data to examine false-positive meningococcal disease reporting and adjust disease incidence estimates for children in New South Wales, Australia.

Authors:  A Gibson; L Jorm; P McIntyre
Journal:  Epidemiol Infect       Date:  2015-01-09       Impact factor: 4.434

3.  Meningococcal disease epidemiology in Australia 10 years after implementation of a national conjugate meningococcal C immunization programme.

Authors:  G L Lawrence; H Wang; M Lahra; R Booy; P B McINTYRE
Journal:  Epidemiol Infect       Date:  2016-04-20       Impact factor: 4.434

4.  Modelled evaluation of multi-component meningococcal vaccine (Bexsero®) for the prevention of invasive meningococcal disease in infants and adolescents in the UK.

Authors:  J Huels; K M Clements; L J McGARRY; G J Hill; J Wassil; S Kessabi
Journal:  Epidemiol Infect       Date:  2013-11-28       Impact factor: 4.434
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.